港股收評:指數衝高回落!恒指微跌0.02%,消費股低迷,新秀麗大跌近9%
港股三大指數早盤衝高午後開盤快速走低,截止收盤,恒指微幅下跌0.02%,國指升0.17%,恒生科技指數跌0.33%表現相對最弱。盤面上,大型科技股多數表現弱勢,阿里巴巴跌超2%,百度、快手、騰訊、京東跌超1%,網易升近4%,小米升超2%;中電聯預計後期煤炭現貨價格延續震盪偏弱運行,尚不具備大幅下跌的條件,煤炭股回暖,中國神華升超3%;軍工股、海運股、電信股走勢活躍,三大運營商齊升,公司將於明日公佈中期業績,中國聯通盤中升超3%。另一方面,香港本地股消費股表現低迷,新秀麗大跌近9%,重型機械股、體育用品股普跌,昨日大幅上升的豬肉概念股走低,龍頭萬洲國際跌1%,昨日大升超8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.